Clin2
NCT07219589Possibly a fitRecruiting

Study of HM17321 in healthy and obese participants

ObesityObese

Part of Hormones & metabolism clinical trials.

This trial tests a new medicine, HM17321, to see how the body processes it. It is for healthy adults and adults with obesity who want to help find new treatment options.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
90 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have a stable weight (less than 5% change) in the last 3 months.
  • You are either healthy with a BMI of 20 to 27, or you have obesity with a BMI of 30 to 45.
  • If you are male, you agree to use contraception or not have unprotected sex with women who could become pregnant.
  • If you are female, you are not pregnant or breastfeeding and use effective birth control.
  • You do not have serious health issues like liver, pancreas, heart, kidney, or thyroid disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07566390Recruiting· Phase 1
Testing a new weight-loss medicine in healthy adults

This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.

Glendale, California
NCT07716241Not yet recruiting· Phase 1
Study of HS-20136-2 for healthy or obese adults

This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.

Hefei
NCT07693868Recruiting· Phase 1
Study of a new medicine for obesity in healthy and overweight people

This study tests a new medicine (NNC6022-0004) in healthy volunteers and people with obesity to check its safety. If you qualify, you may help see if this drug is safe for future use.

Groningen
NCT07754474Not yet recruiting· Phase 1
Testing a new medicine for overweight or obesity

This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.

Mannheim
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.